Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
Sponsor: Samsung Medical Center
Summary
This prospective study enrolls patients who are diagnosed with aggressive lymphoma including Hodgkin and non-Hodgkin lymphomas. Enrolled patients will be treated according to our institution' treatment policy in clinical practice. The disease status including response to therapy and survival status will be regularly updated during the study period. Patients' serum and cell-free DNA will be collected and analyzed.
Official title: A Prospective Study for Patients With Lymphoid Malignancy at the Samsung Medical Center
Key Details
Gender
All
Age Range
20 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2017-03-01
Completion Date
2026-12-28
Last Updated
2025-05-21
Healthy Volunteers
No
Conditions
Interventions
Chemotherapy
Systemic chemotherapy with curative intent
Locations (1)
Samsung Medical Center
Seoul, South Korea